Search research articles
Contact Us
Filters
Showing results (91-100 of 93) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 93 results.
The Lancet. Respiratory Medicine
|
July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P Tashkin, Michael D Roth, Philip J Clements, et al.
Arthritis and Rheumatism
|
October 15, 2013
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Annals of the Rheumatic Diseases
|
October 5, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 93) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 93 results.
The Lancet. Respiratory Medicine
|
July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P Tashkin, Michael D Roth, Philip J Clements, et al.
Arthritis and Rheumatism
|
October 15, 2013
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Annals of the Rheumatic Diseases
|
October 5, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Page
of 10